DH DIAGNOSTICS LLC

Lobbying for DH DIAGNOSTICS, LLC · Diagnostics manufacturers

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$250,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Government bodies contacted 5

Defense, Dept of (DOD)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 8

HR 7352
PASTEUR Act of 2026
S 1941
Cure Hepatitis C Act of 2025
S 2761
RESULTS Act
HR 5269
RESULTS Act
S 1399
Health Tech Investment Act
HR 6197
Health Tech Investment Act
S 3287
Supportive Services for National Guard and Reserve Veterans and Families Act
HR 6130
ASAP Act

Lobbying activity 3

Health Issues

Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025

Medicare/Medicaid

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Budget/Appropriations

Funding for diagnostics

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.